LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 149

Search options

  1. Article ; Online: Sex differences in tissue immunity.

    Puttur, Franz / Lloyd, Clare M

    Science (New York, N.Y.)

    2024  Volume 384, Issue 6692, Page(s) 159–160

    Abstract: Androgen signaling skews skin immunity toward reduced inflammation in male mice. ...

    Abstract Androgen signaling skews skin immunity toward reduced inflammation in male mice.
    MeSH term(s) Male ; Female ; Mice ; Animals ; Androgens ; Sex Characteristics ; Immunity, Innate ; Lymphocytes ; Dendritic Cells
    Chemical Substances Androgens
    Language English
    Publishing date 2024-04-04
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.ado8542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Breathing easy: Dopamine quenches the ILC2 flame.

    Puttur, Franz / Lloyd, Clare M

    Immunity

    2023  Volume 56, Issue 2, Page(s) 229–231

    Abstract: Communication between nerves and group 2 innate lymphoid cells (ILC2s) is thought to regulate allergic airway inflammation, but the molecular mechanisms are unclear. In this issue of Immunity, Cao et al. uncover an essential role for dopamine in ... ...

    Abstract Communication between nerves and group 2 innate lymphoid cells (ILC2s) is thought to regulate allergic airway inflammation, but the molecular mechanisms are unclear. In this issue of Immunity, Cao et al. uncover an essential role for dopamine in inhibiting ILC2 function via metabolic restriction, thereby ameliorating key features of asthma pathogenesis.
    MeSH term(s) Humans ; Immunity, Innate ; Dopamine ; Lymphocytes ; Asthma ; Inflammation ; Cytokines/metabolism
    Chemical Substances Dopamine (VTD58H1Z2X) ; Cytokines
    Language English
    Publishing date 2023-02-07
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2023.01.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Early-life respiratory infections and developmental immunity determine lifelong lung health.

    Lloyd, Clare M / Saglani, Sejal

    Nature immunology

    2023  Volume 24, Issue 8, Page(s) 1234–1243

    Abstract: Respiratory infections are common in infants and young children. However, the immune system develops and matures as the child grows, thus the effects of infection during this time of dynamic change may have long-term consequences. The infant immune ... ...

    Abstract Respiratory infections are common in infants and young children. However, the immune system develops and matures as the child grows, thus the effects of infection during this time of dynamic change may have long-term consequences. The infant immune system develops in conjunction with the seeding of the microbiome at the respiratory mucosal surface, at a time that the lungs themselves are maturing. We are now recognizing that any disturbance of this developmental trajectory can have implications for lifelong lung health. Here, we outline our current understanding of the molecular mechanisms underlying relationships between immune and structural cells in the lung with the local microorganisms. We highlight the importance of gaining greater clarity as to what constitutes a healthy respiratory ecosystem and how environmental exposures influencing this network will aid efforts to mitigate harmful effects and restore lung immune health.
    MeSH term(s) Infant ; Child ; Humans ; Child, Preschool ; Lung ; Respiratory Tract Infections ; Microbiota ; Immune System ; Respiratory Mucosa
    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-023-01550-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: T helper 2 cells in asthma.

    Harker, James A / Lloyd, Clare M

    The Journal of experimental medicine

    2023  Volume 220, Issue 6

    Abstract: Allergic asthma is among the most common immune-mediated diseases across the world, and type 2 immune responses are thought to be central to pathogenesis. The importance of T helper 2 (Th2) cells as central regulators of type 2 responses in asthma has, ... ...

    Abstract Allergic asthma is among the most common immune-mediated diseases across the world, and type 2 immune responses are thought to be central to pathogenesis. The importance of T helper 2 (Th2) cells as central regulators of type 2 responses in asthma has, however, become less clear with the discovery of other potent innate sources of type 2 cytokines and innate mediators of inflammation such as the alarmins. This review provides an update of our current understanding of Th2 cells in human asthma, highlighting their many guises and functions in asthma, both pathogenic and regulatory, and how these are influenced by the tissue location and disease stage and severity. It also explores how biologics targeting type 2 immune pathways are impacting asthma, and how these have the potential to reveal hitherto underappreciated roles for Th2 cell in lung inflammation.
    MeSH term(s) Humans ; Th2 Cells ; Asthma ; Cytokines/metabolism ; Inflammation/pathology ; Pneumonia/pathology ; Immunity, Innate
    Chemical Substances Cytokines
    Language English
    Publishing date 2023-05-10
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 218343-2
    ISSN 1540-9538 ; 0022-1007
    ISSN (online) 1540-9538
    ISSN 0022-1007
    DOI 10.1084/jem.20221094
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Pseudomonas aeruginosa: a pathogen making itself at home.

    Stölting, Helen / Lloyd, Clare M

    Trends in immunology

    2022  Volume 43, Issue 7, Page(s) 497–499

    Abstract: Upon bacterial infection, mounting the appropriate immune response is paramount to effective pathogen clearance. In a recent study, Agaronyan et al. show how Pseudomonas aeruginosa can divert host immunity to boost type 2 responses and drive mucus ... ...

    Abstract Upon bacterial infection, mounting the appropriate immune response is paramount to effective pathogen clearance. In a recent study, Agaronyan et al. show how Pseudomonas aeruginosa can divert host immunity to boost type 2 responses and drive mucus production, which can then act as a nutrient source for bacteria.
    MeSH term(s) Humans ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/physiology
    Language English
    Publishing date 2022-05-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2022.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Immunoregulation of asthma by type 2 cytokine therapies: Treatments for all ages?

    Saglani, Sejal / Yates, Laura / Lloyd, Clare M

    European journal of immunology

    2023  Volume 53, Issue 8, Page(s) e2249919

    Abstract: Asthma is classically considered to be a disease of type 2 immune dysfunction, since many patients exhibit the consequences of excess secretion of cytokines such as IL-4, IL-5, and IL-13 concomitant with inflammation typified by eosinophils. Mouse and ... ...

    Abstract Asthma is classically considered to be a disease of type 2 immune dysfunction, since many patients exhibit the consequences of excess secretion of cytokines such as IL-4, IL-5, and IL-13 concomitant with inflammation typified by eosinophils. Mouse and human disease models have determined that many of the canonical pathophysiologic features of asthma may be caused by these disordered type 2 immune pathways. As such considerable efforts have been made to develop specific drugs targeting key cytokines. There are currently available multiple biologic agents that successfully reduce the functions of IL-4, IL-5, and IL-13 in patients, and many improve the course of severe asthma. However, none are curative and do not always minimize the key features of disease, such as airway hyperresponsiveness. Here, we review the current therapeutic landscape targeting type 2 immune cytokines and discuss evidence of efficacy and limitations of their use in adults and children with asthma.
    MeSH term(s) Adult ; Child ; Humans ; Animals ; Mice ; Interleukin-13 ; Interleukin-5 ; Interleukin-4 ; Asthma ; Eosinophils ; Cytokines
    Chemical Substances Interleukin-13 ; Interleukin-5 ; Interleukin-4 (207137-56-2) ; Cytokines
    Language English
    Publishing date 2023-04-03
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.202249919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Overlapping and distinct features of viral and allergen immunity in the human lung.

    Harker, James A / Lloyd, Clare M

    Immunity

    2021  Volume 54, Issue 4, Page(s) 617–631

    Abstract: Immunity in the human respiratory tract is provided by a diverse range of tissue-resident cells, including specialized epithelial and macrophage populations and a network of innate and innate-like lymphocytes, such as natural killer cells, innate ... ...

    Abstract Immunity in the human respiratory tract is provided by a diverse range of tissue-resident cells, including specialized epithelial and macrophage populations and a network of innate and innate-like lymphocytes, such as natural killer cells, innate lymphoid cells, and invariant T cells. Lung-resident memory T and B cells contribute to this network following initial exposure to antigenic stimuli. This review explores how advances in the study of human immunology have shaped our understanding of this resident immune network and its response to two of the most commonly encountered inflammatory stimuli in the airways: viruses and allergens. It discusses the many ways in which pathogenic infection and allergic inflammation mirror each other, highlighting the key checkpoints at which they diverge and how this can result in a lifetime of allergic exacerbation versus protective anti-viral immunity.
    MeSH term(s) Allergens/immunology ; Animals ; Humans ; Immunity, Innate/immunology ; Inflammation/immunology ; Inflammation/virology ; Lung/immunology ; Lung/virology ; Lymphocytes/immunology ; Respiratory Tract Infections/immunology ; Respiratory Tract Infections/virology ; Virus Diseases/immunology
    Chemical Substances Allergens
    Language English
    Publishing date 2021-04-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2021.03.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Regulation of immune responses by the airway epithelial cell landscape.

    Hewitt, Richard J / Lloyd, Clare M

    Nature reviews. Immunology

    2021  Volume 21, Issue 6, Page(s) 347–362

    Abstract: The community of cells lining our airways plays a collaborative role in the preservation of immune homeostasis in the lung and provides protection from the pathogens and pollutants in the air we breathe. In addition to its structural attributes that ... ...

    Abstract The community of cells lining our airways plays a collaborative role in the preservation of immune homeostasis in the lung and provides protection from the pathogens and pollutants in the air we breathe. In addition to its structural attributes that provide effective mucociliary clearance of the lower airspace, the airway epithelium is an immunologically active barrier surface that senses changes in the airway environment and interacts with resident and recruited immune cells. Single-cell RNA-sequencing is illuminating the cellular heterogeneity that exists in the airway wall and has identified novel cell populations with unique molecular signatures, trajectories of differentiation and diverse functions in health and disease. In this Review, we discuss how our view of the airway epithelial landscape has evolved with the advent of transcriptomic approaches to cellular phenotyping, with a focus on epithelial interactions with the local neuronal and immune systems.
    MeSH term(s) Animals ; Apoptosis/immunology ; Cellular Microenvironment/genetics ; Cellular Microenvironment/immunology ; Circadian Rhythm/genetics ; Circadian Rhythm/immunology ; Epithelial Cells/classification ; Epithelial Cells/immunology ; Epithelial Cells/metabolism ; Genetic Markers ; Humans ; Immunologic Memory ; Mice ; Models, Immunological ; Neuroendocrine Cells/immunology ; Neuroendocrine Cells/metabolism ; Neuroimmunomodulation ; RNA-Seq ; Respiratory Mucosa/cytology ; Respiratory Mucosa/immunology ; Respiratory Mucosa/metabolism ; Single-Cell Analysis
    Chemical Substances Genetic Markers
    Language English
    Publishing date 2021-01-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-020-00477-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Regulatory cytokine function in the respiratory tract.

    Branchett, William J / Lloyd, Clare M

    Mucosal immunology

    2019  Volume 12, Issue 3, Page(s) 589–600

    Abstract: The respiratory tract is an important site of immune regulation; required to allow protective immunity against pathogens, while minimizing tissue damage and avoiding aberrant inflammatory responses to inhaled allergens. Several cell types work in concert ...

    Abstract The respiratory tract is an important site of immune regulation; required to allow protective immunity against pathogens, while minimizing tissue damage and avoiding aberrant inflammatory responses to inhaled allergens. Several cell types work in concert to control pulmonary immune responses and maintain tolerance in the respiratory tract, including regulatory and effector T cells, airway and interstitial macrophages, dendritic cells and the airway epithelium. The cytokines transforming growth factor β, interleukin (IL-) 10, IL-27, and IL-35 are key coordinators of immune regulation in tissues such as the lung. Here, we discuss the role of these cytokines during respiratory infection and allergic airway disease, highlighting the critical importance of cellular source and immunological context for the effects of these cytokines in vivo.
    MeSH term(s) Animals ; Cytokines/metabolism ; Dendritic Cells/immunology ; Homeostasis ; Humans ; Hypersensitivity/immunology ; Immune Tolerance ; Lung/immunology ; Respiratory Mucosa/immunology ; Respiratory System/immunology ; Respiratory Tract Infections/immunology ; T-Lymphocytes, Regulatory/immunology
    Chemical Substances Cytokines
    Language English
    Publishing date 2019-03-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2411370-0
    ISSN 1935-3456 ; 1933-0219
    ISSN (online) 1935-3456
    ISSN 1933-0219
    DOI 10.1038/s41385-019-0158-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Opening the Window of Immune Opportunity: Treating Childhood Asthma.

    Lloyd, Clare M / Saglani, Sejal

    Trends in immunology

    2019  Volume 40, Issue 9, Page(s) 786–798

    Abstract: Asthma is an increasingly common childhood disease and although most patients can control their symptoms with medication, a proportion experience life-threatening symptoms. The advent of novel biologic therapies represents a giant leap forward for asthma ...

    Abstract Asthma is an increasingly common childhood disease and although most patients can control their symptoms with medication, a proportion experience life-threatening symptoms. The advent of novel biologic therapies represents a giant leap forward for asthma treatment, but efficacy is rarely tested in children. Recent mechanistic work in mice suggests that early life is a key period for immune development and, therefore, allergen sensitization. Although children with severe asthma experience significant comorbidities and are at increased risk for serious diseases such as chronic obstructive pulmonary disease as adults, no specific investigation into tailored treatment for young children with severe asthma exists. Here, we propose how new information regarding early life immunity could be used to inform modified treatments for children.
    MeSH term(s) Asthma/immunology ; Asthma/therapy ; Child ; Humans
    Language English
    Publishing date 2019-08-14
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2019.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top